DL Chemical group Issuer Summary

Report date: 2026-05-18
Issuer: DL Chemical group
Relevant market reference: KRA / Kraton Corporation legacy market identifier
Relevant bond reference: Kraton Corporation USD global bonds with Korea Development Bank guarantee

1. Business Snapshot and Recent Developments

DL Chemical group is a petrochemical and specialty materials group under Korea's DL Holdings. The first point bond investors need to clarify when looking at this credit is that it is not simply a Korean petrochemical company. It is a post-acquisition composite chemicals group combining Korean PE, PB and EPO operations; Kraton's SBC and Pine chemical businesses, mainly in the US and Europe; Cariflex's synthetic rubber and latex for medical applications; DL FnC's BOPP film; and D-REX Polymer's APAO. The market entry point using the identifier KRA derives from the former listed ticker of Kraton Corporation, which came under DL Chemical in 2022. This report therefore distinguishes between the business and financial credit of DL Chemical group and the post-guarantee credit of the KDB-guaranteed global bonds issued by Kraton.

The information on the KDB-guaranteed bonds that could be confirmed for this report is mainly based on Kraton's press release and Moody's published headline. The full text of the offering circular, KDB guarantee deed, guarantee claim procedures, cross default, change of control, negative pledge and other provisions has not been reviewed. Therefore, while the KDB guarantee should directionally be viewed as a very strong credit enhancement, individual bond investment requires confirmation that the guarantee is unconditional, irrevocable, pari passu and timely-payment in nature.

DL Chemical's official website positions the company as having led Korea's petrochemical industry and states that it is the global leader in the open market for PB and that Cariflex has a high global share in synthetic rubber and latex for medical gloves. Kraton is a global company that handles specialty polymers such as SBC and Pine chemical products using crude tall oil, a pulp by-product, as feedstock. Compared with a commodity naphtha cracker or a simple polyethylene company, these businesses have more diversified applications, customers, technologies and sales regions, making it easier to build a degree of earnings floor. On the other hand, the businesses remain exposed to raw material prices, utilisation rates, spreads, foreign exchange, interest rates and acquisition-related burdens, so it cannot simply be said that they are stable because they are specialty chemicals.

The latest credit developments should be viewed in two parts. The first is that, in July 2024, Kraton issued USD1.0bn of three-year global bonds, with a credit guarantee from Korea Development Bank (KDB). Kraton's press release explains that the KDB guarantee lowered the cost of capital for the bonds and attracted demand from global investors. Moody's published headline also states that the KDB-guaranteed Kraton notes were assigned an Aa2 rating. This is not in itself a credit improvement of Kraton stand-alone or DL Chemical group stand-alone; it is financing that incorporates KDB credit at the bond level. For investors holding this bond, therefore, the central risks are not only volatility in Kraton's business, but also the legal effectiveness of the guarantee, KDB's credit, the practical process for guarantee claims and confirmation of individual terms.

The second is the slowdown in profitability at DL Holdings consolidated level and in the chemical business in 2025. According to DL Holdings' official financial information and 4Q 2025 materials, DL Holdings' consolidated 2025 revenue was KRW5.327tn, operating profit was around KRW298.5bn and net loss was KRW96.3bn. In 2024, revenue was KRW5.615tn, operating profit KRW412.5bn and net profit KRW94.8bn, meaning revenue declined slightly, operating profit fell by about 30%, and the bottom line turned to a loss. On the chemical side, DL Chemical consolidated operating profit in 2025 is stated to have fallen sharply to KRW80.6bn from KRW202.1bn in 2024. DL Holdings' 4Q materials explain that Kraton turned loss-making in 4Q due to seasonal volume decline and spread compression, while non-operating expenses, interest, foreign exchange and Kraton-related impairments weighed on net income.

However, there were signs of partial recovery in 1Q 2026. According to external news reports covering DL's preliminary results announcement on 8 May 2026, DL Holdings' consolidated 1Q 2026 revenue was KRW1.2828tn and operating profit was KRW112.9bn, with operating profit increasing year on year and improving sharply quarter on quarter. The reports state that chemicals and energy supported the earnings recovery; DL Chemical's PB maintained high margins; PE profitability improved as price increases were reflected; and Kraton saw utilisation rates and sales recover from year-end seasonal factors. This is evidence that 4Q 2025 may have marked a temporary trough, but because a complete 1Q table for the chemical segment could not be directly extracted from an official PDF, this report treats 1Q 2026 as an "initial confirmation of recovery" and does not yet conclude that there has been a structural improvement.

In short, DL Chemical group is a Korean chemicals group with strong niche products and global specialty chemical operations, but where investors need to distinguish between the financial burden after the Kraton acquisition, petrochemical market conditions, foreign exchange and interest rates, and the parent-subsidiary and guarantee structures. For bond investors, the key questions are how far PB, Cariflex and Kraton's technology and customer base can limit business downside; how strong the protection under the KDB-guaranteed bond is; and how much cushion DL Chemical group's own unsecured credit has.

2. Industry Position and Franchise Strength

DL Chemical group's business base sits between commodity petrochemicals and specialty chemicals. Korea-based DL Chemical separate handles PE, PB, EPO and other products, and is also connected to the industrial base for basic feedstocks, PP and NCC through affiliates such as YNCC and PolyMirae. However, affiliates are not direct repayment sources for creditors, so business linkage and legally accessible cash flow need to be analysed separately.

DL Chemical separate's competitiveness lies in its PB, PE and EPO technologies and operating track record. The official website highlights its global leading position in the open market for PB, PB annual production capacity of 200,000 tonnes, and its ability to produce Con-PB and HR PB on the same facilities. PB is used in lubricants, adhesives, fuel additives, films, sealants and other applications, and customer specifications and stable supply support pricing power. On the other hand, if naphtha, butadiene, styrene, demand, inventories and foreign exchange move simultaneously, profits can fall even with technological advantages. The decline in chemical profit in 2025 demonstrated this point.

Kraton handles specialty polymers including SBC and Pine chemical products, selling into a broad range of applications including adhesives, coatings, consumer goods, medical, packaging, automotive, paving, tyres and oilfield chemicals. Application diversification and product specification are credit supports, but SBC is affected by styrene, butadiene and isoprene, while Pine chemical is affected by crude tall oil and other inputs. Kraton's loss in 4Q 2025 showed that, despite its specialty chemical base, the company is sensitive to volume, spreads, seasonality and fixed costs.

Cariflex is said to have a high global share in synthetic rubber and latex for medical gloves, and is a credit-supportive business within DL Chemical group. However, its scale is smaller than Kraton's, and it also has risks related to inventory adjustments in medical supplies, customer concentration and expansion investment in Singapore. DL Chemical group's strengths are specialty products and regional diversification; its weaknesses are that it simultaneously carries larger overseas operations after acquisitions, fixed-cost, raw-material and foreign-exchange risks as a cyclical industry, and post-acquisition burdens.

3. Segment Assessment

For segment assessment, it is important not to mix DL Holdings consolidated, DL Chemical group, DL Chemical separate, Kraton and Cariflex. DL Holdings consolidated includes not only chemicals but also energy, motor, hotel, investment and other businesses. DL Chemical group is the centre of the chemicals business, but it includes Korea-based DL Chemical separate, Kraton, Cariflex, DL FnC, D-REX Polymer, overseas sales companies and affiliates. When assessing Kraton's KDB-guaranteed bonds, it is also necessary to distinguish the issuer perimeter of Kraton Corporation from the KDB guarantee.

DL Chemical separate is a Korean manufacturing company centred on PE/PB/EPO. According to mirrored information from DL Holdings' 4Q 2025 materials, DL Chemical separate's 2025 revenue was KRW1.509tn, down from KRW1.827tn in 2024. Quarterly materials show 2025 revenue of KRW444.4bn in 1Q, KRW367.2bn in 2Q, KRW374.3bn in 3Q and KRW323.2bn in 4Q, indicating weakness versus the prior-year level throughout 2025. Operating profit was KRW43.4bn in 1Q 2025, KRW24.4bn in 2Q, KRW24.0bn in 3Q and appears to have fallen into negative territory in 4Q. This indicates that even if PB provides support, the business remains exposed to PE and other products, inventory and lag effects during raw material price declines, and spread compression.

Kraton is the largest contributor to group revenue. According to the mirror of DL Holdings' 4Q 2025 materials, Kraton's 2025 revenue was KRW2.742tn, slightly down from KRW2.769tn in 2024. Operating profit was KRW3.3bn in 1Q 2025, KRW4.5bn in 2Q, KRW3.0bn in 3Q and appears to have been a loss of around KRW56.1bn in 4Q, with profitability very thin for the full year. Kraton has application diversification and product technology, but its 2025 results show that it is exposed to fixed costs, market deterioration, volume decline, spread compression, and impairment and restructuring costs. Given Kraton's large revenue scale, recovery in its margin will determine the credit direction of DL Chemical group as a whole.

Cariflex is smaller than Kraton, but important as a support for profitability. According to mirrors of DL Holdings' 2Q/3Q 2025 materials, Cariflex maintained a high operating margin from 1Q to 3Q 2025. In 2Q 2025, revenue was KRW50.0bn, operating profit KRW9.2bn and operating margin 18.4%; in 3Q, revenue was KRW63.9bn, operating profit KRW11.5bn and operating margin 18.0%. For full-year 2024, revenue was KRW239.7bn, operating profit KRW47.4bn and operating margin 19.8%. Cariflex supports group-wide margins, but because its revenue scale is less than one-tenth of Kraton's, it has limited capacity to absorb all of Kraton's losses or the profit slowdown at DL Chemical separate.

DL FnC, D-REX Polymer, NOTARK and related JVs are supplementary businesses from a credit analysis standpoint. BOPP film, APAO, next-generation resins, PP and NCC-related businesses broaden the group's product portfolio and technology base. However, because their individual operating profit, cash flow and investment burden are not sufficiently disclosed, this report does not make them core pillars of the credit conclusion. D-REX Polymer has begun commercial production of APAO, which has long-term significance as a higher-value-added material for adhesives and packaging, but at this stage it should not be viewed as having reached a scale sufficient to offset earnings volatility at Kraton and DL Chemical separate.

The table below summarises the positioning of each business segment that could be confirmed from public information. The figures are based on DL Holdings materials mirrors, the official website and fragmentary extracts from DART/KRX, and are not a complete audited segment table.

Given this segment structure, the core credit factors are Kraton normalisation and DL Chemical separate's PB/PE margins. Cariflex is a high-quality support, but not large enough to determine the overall credit profile. For DL Chemical group to improve its credit quality, it needs to eliminate Kraton's losses, impairments and low margins; maintain high profitability in PB and Cariflex; and avoid excessive market-related losses in PE and related materials.

4. Financial Profile and Analysis

In financial analysis, it is important to use DL Holdings' consolidated figures while avoiding overstatement of DL Chemical group's credit. DL Holdings discloses consolidated financial information, and revenue, operating profit and net profit/loss from 2023 to 2025 can be confirmed. On the other hand, complete operating cash flow, FCF, gross debt, short-term debt and unused committed lines for DL Chemical group alone could not be directly extracted at the time of this initial report. Therefore, this section combines confirmed figures for the parent consolidated level, the chemical segment, DL Chemical separate, Kraton and Cariflex, while clearly identifying unconfirmed items.

DL Holdings' consolidated profit and loss improved sharply in 2024 and then weakened in 2025. Official financial information shows 2023 revenue of KRW5.018tn, operating profit of KRW150.7bn and net loss of KRW121.0bn; 2024 revenue of KRW5.615tn, operating profit of KRW412.5bn and net profit of KRW94.8bn; and 2025 revenue of KRW5.327tn, operating profit of KRW298.5bn and net loss of KRW96.3bn. The 2025 operating margin was about 5.6%, down from about 7.3% in 2024. The mirror of the 4Q 2025 materials also shows operating profit down 27.8% year on year. This indicates that the business as a whole remained operating-profit positive, but after non-operating factors such as interest, foreign exchange, impairments and equity-method gains/losses, the cushion in net income became thin.

The cash flow and debt data that are inherently necessary for an unsecured credit assessment remain unconfirmed in this initial report, as set out below. This information gap is why DL Chemical group should be treated as a carefully monitored credit, rather than assumed to be stable merely because there is parent-level consolidated cash.

At the DL Chemical group level, profit fell sharply in 2025. According to the mirror of DL Holdings' 4Q materials, DL Chemical consolidated operating profit declined from KRW202.1bn in 2024 to KRW80.6bn in 2025. This is very important for the group's overall credit assessment. Operating profit remained positive, but given the post-Kraton-acquisition group scale, goodwill and intangible assets, foreign-currency and interest burden, operating profit of around KRW80bn cannot be described as providing a thick financial cushion.

Several factors overlapped behind the 2025 profit decline. At DL Chemical separate, PB appears to have been relatively strong, while PE and petrochemical spreads were weak. At Kraton, volume decline, spread compression, seasonality, sluggish US and European demand, fluctuations in Pine chemical raw material and product prices, and fixed-cost burden overlapped. DL Holdings materials cite Kraton's 4Q loss and Kraton impairment, and the gap between the earnings capacity assumed at the time of acquisition and actual cash generation has become a credit constraint.

From a liquidity perspective, however, cash is reasonably substantial at the parent consolidated level. According to KRX/DART extracts of DL Holdings' 2025 consolidated financial statements, cash and cash equivalents at year-end 2025 were KRW1.148tn, short-term financial instruments were KRW18.9bn and current assets were KRW2.912tn. At end-2024, cash was KRW877.6bn, short-term financial instruments KRW123.5bn and current assets KRW2.879tn. Cash increased, which is evidence of funding capacity at the parent consolidated level. However, DL Holdings' consolidated cash is a figure for the whole group including energy, hotel, investment and other businesses, and does not directly belong to creditors of Kraton or DL Chemical domestic bonds. Without confirming the legal-entity location of cash, foreign-currency cash, bank lines, collateral, dividend restrictions and restrictions on movement of funds from subsidiaries to the parent, the stand-alone liquidity of the issuer should not be described as strong.

DART/KRX extracts as of 1Q 2025 showed, for the main subsidiary perimeter corresponding to DL Chemical group, current assets of KRW2.066tn, non-current assets of KRW5.778tn, current liabilities of KRW1.584tn, non-current liabilities of KRW4.537tn, controlling shareholders' equity of KRW1.474tn and non-controlling interests of KRW250bn. The notes indicate that this perimeter includes Kraton and Cariflex. However, the figures used here are extract-based and were not directly extracted from a complete audited full-year 2025 table. If this balance sheet structure has not changed materially, DL Chemical group has large assets but also substantial liabilities, and its equity buffer cannot be described as large. Current assets exceeding current liabilities supports short-term liquidity, but the weight of non-current liabilities, goodwill and intangible assets related to the Kraton acquisition, foreign-currency debt and interest burden are credit constraints.

Cash flow is the most important unconfirmed item in this report. Even with operating profit, operating cash flow and FCF can fluctuate significantly in petrochemicals and specialty chemicals due to inventories, receivables, raw material prices, capex, environmental investment, restructuring costs, interest and foreign exchange. Kraton is affected by raw material inventory and logistics for Pine chemical and by utilisation rates in its polymers business. DL Chemical separate is also affected by naphtha and olefin prices, inventory valuation and customer collections. Cariflex has high margins, but expansion investment and customer inventory adjustments can also change cash flow. Therefore, in the next update, DL Chemical group's operating cash flow, capex, dividends, M&A, debt repayment and changes in short-term borrowings need to be directly confirmed from official materials.

The current financial assessment is that the group has an operating base, but financial headroom is not strong for unsecured credit excluding KDB-guaranteed bonds. DL Holdings' consolidated cash and the earnings recovery in 1Q 2026 are supportive, but the decline in chemical profit in 2025, Kraton's loss, acquisition-related impairments and the turn to net loss are clear constraints on DL Chemical group's credit quality. Even when evaluating the post-guarantee credit of the guaranteed bond, bond investors should not ignore the underlying credit of Kraton and DL Chemical group. The guarantee does not eliminate business risk; it only changes the structure so that expected loss on the guaranteed bond depends heavily on the guarantor.

5. Structural Considerations for Bondholders

For DL Chemical group bond investors, the most important structural point is that the credit source differs depending on which bond is being analysed. When viewed through the KRA market code, the relevant credit is often linked to Kraton Corporation. Kraton is now controlled through DLC US Holdings, a subsidiary of DL Chemical, and DL Chemical itself is an 88.90% subsidiary of DL Holdings. It is therefore necessary to distinguish the legal claim of Kraton creditors, parent support for DL Chemical group, the headroom of DL Holdings consolidated, and the presence or absence of a KDB guarantee.

Kraton's USD1.0bn global bond issued in 2024 is significantly different from ordinary corporate bonds because it is KDB-guaranteed. Kraton's press release states that it is a three-year bond with a KDB credit guarantee and that investors from Asia, Europe and the US participated. Moody's headline states that it assigned Aa2 to the KDB-guaranteed Kraton notes. This does not mean that Kraton's stand-alone credit quality is Aa2. The credit assessment of the guaranteed notes should be understood as being based on KDB's capacity to pay and the legal enforceability of the guarantee.

This distinction is important for investment decisions. Investors holding KDB-guaranteed Kraton bonds may rely on KDB credit as long as the guarantee is properly triggered, even if Kraton's business deteriorates. In contrast, DL Chemical group's unsecured bonds, DL Chemical domestic bonds, DL Holdings parent bonds and any non-guaranteed Kraton bonds, if present, would have different recovery rankings and credit sources from the guaranteed bonds. It would be incorrect to look at Kraton's KDB-guaranteed bonds and infer that DL Chemical group as a whole has equivalently high credit quality.

Parent support also needs to be viewed cautiously. DL Holdings owns 88.90% of DL Chemical, and DL Chemical controls Kraton and Cariflex. In 2025, there were also disclosures indicating parent or intragroup capital support, such as paid-in capital increases for DL Chemical. This can be a credit support. However, DL Holdings is a listed holding company, and it owns not only chemicals but also energy, motor, hotel, investment and real-estate-related businesses. The parent may not always support the chemicals business unconditionally, and support depends on capital policy, minority shareholders, ratings, funding conditions and intragroup priorities.

For DL Chemical domestic bonds, extracts from DART/KRX quarterly reports indicate that DL Chemical's domestic public bonds have provisions relating to financial ratio maintenance, restrictions on collateral creation, restrictions on asset disposals and changes in control structure, and that compliance with financial ratios and collateral ratios was shown as of end-2024. The extracts confirm that DL Chemical's 264-2 public bond matures on 28 May 2025, and that separate DL Energy bonds and DL Holdings bonds also have provisions. However, these provisions are protections under domestic public bond management agreements and are different from the guarantees and covenants of the Kraton USD bonds. Offshore bond investors need to separately confirm the OC, guarantee agreement, negative pledge, change of control, cross default, tax gross-up, substitution of obligor, guarantee claim procedures and KDB payment timing.

Structural subordination should also be considered. DL Holdings parent bonds rely on dividends, brand fees and capital recovery from subsidiaries. DL Chemical domestic bonds rely on DL Chemical's Korean business, subsidiary shares, dividends and fund transfers. Kraton bonds depend on Kraton's business and the presence or absence of a guarantee. Even if overseas subsidiaries such as Cariflex or Kraton have cash, unless it is confirmed which legal entity holds that cash and whether collateral, borrowings, tax, minority shareholders or local regulations restrict it, creditors of the parent or another legal entity cannot be assumed to have free access to it.

Structural analysis for bondholders should therefore be carried out in two stages. First, confirm whether the target bond has a guarantee, who the guarantor is, and whether the guarantee is unconditional, irrevocable and pari passu. Second, when assessing non-guaranteed risk or risks outside the guarantee, confirm in which legal entity operating cash flow is generated, which legal entity has debt, and where restrictions on fund transfers exist across Kraton, DL Chemical and DL Holdings. At the time of this initial report, the full guarantee terms for the guaranteed Kraton bonds have not been reviewed. The KDB guarantee is directionally a major support, but term confirmation is essential before investing in the individual bond.

6. Capital Structure, Liquidity and Funding

Kraton's KDB-guaranteed bond is important in assessing DL Chemical group's capital structure, but it is not sufficient by itself to assess liquidity risk for the whole group. In July 2024, Kraton issued USD1.0bn of three-year global bonds, with proceeds described as being used for refinancing existing debt and general corporate purposes. The KDB guarantee lowered the interest rate and enabled access to a global investor base, reducing Kraton's short- to medium-term refinancing burden. Particularly in 2025, when Kraton's profitability declined, the fact that it had secured a large amount of guaranteed funding in 2024 was an important liquidity support.

However, this financing does not mean that Kraton's stand-alone credit quality can independently maintain global investment-grade funding. Moody's-related headlines refer to Kraton stand-alone being downgraded to B1 in June 2024, and mention earnings deterioration, rising leverage and tight liquidity. This shows the wide gap between the Aa2 rating of the KDB-guaranteed bond and Kraton's stand-alone credit. Issuer analysis needs to distinguish between interest and principal protection on the guaranteed bond and the underlying turnaround and earnings recovery of Kraton's business.

DL Holdings' consolidated liquidity can be confirmed as of end-2025, with cash and cash equivalents of KRW1.148tn, short-term financial instruments of KRW18.9bn and current assets of KRW2.912tn. This is evidence of funding capacity at the parent consolidated level. In addition, 1Q 2026 preliminary results showed recovery in operating profit, confirming a rebound from the earnings decline in 4Q 2025. Under normal conditions, DL Holdings group appears to have room to refinance through relationships with domestic banks, Korea's capital market, policy financial institutions including KDB and international financial institutions. However, until legal-entity cash, foreign-currency cash, collateral, dividend restrictions, subsidiary debt agreements and intragroup fund transfer constraints are confirmed, this consolidated cash should not be treated as funds directly available to unsecured creditors of Kraton or DL Chemical domestic bonds.

For the unsecured credit of the chemicals business, however, the weight of short-term debt and non-current liabilities cannot be ignored. In the 1Q 2025 DART/KRX extracts, the main DL Chemical subsidiary perimeter including Kraton and Cariflex had current liabilities of KRW1.584tn and non-current liabilities of KRW4.537tn. Although current assets of KRW2.066tn exceeded current liabilities, the size of non-current liabilities, acquisition-related intangible assets, foreign-currency liabilities and interest burden mean that headroom is limited when operating profit is thin. In a period such as 2025, when full-year chemical profit declined and Kraton turned loss-making, access to refinancing markets and the quality of guarantee and parent support become more important than gross debt repayment capacity.

In terms of funding hierarchy, Kraton accessed the international market with a KDB-guaranteed bond. DL Chemical domestic bonds depend on the domestic bond market and financial institutions. DL Holdings parent relies, as a holding company, on subsidiary dividends, asset sales, brand fees and domestic and offshore borrowings. These sources can complement each other within the same group, but priorities may diverge under stress. Funds used to support Kraton's working capital and capex, and funds used for DL Holdings parent dividends, shareholder returns or investments in other businesses, are not the same cash pool.

The next items to confirm for liquidity assessment are legal-entity cash, foreign-currency cash, hedging, unused committed lines, secured borrowings and the short-term borrowing maturity schedule. Because the KDB-guaranteed bond principal appears to be USD-denominated, Kraton's dollar revenue, dollar cash, hedging and guarantee claim procedures are important. Korea-based DL Chemical separate's domestic bonds and bank borrowings are likely mainly KRW-denominated, but dollar, euro and other currency risks remain due to raw materials and transactions with overseas subsidiaries. Because Kraton has US and European operations, USD, EUR and local-currency interest rates and foreign exchange affect earnings and funding.

Capex should also not be overlooked. DART/KRX disclosures confirm investments such as Kraton's ML1D & Belpre BCU Project, DL Chemical's PB, SLBR and green conversion investments, and Cariflex's new Singapore plant. These support cost competitiveness and higher value-added products over the long term, but involve cash outflow and execution risk in the short term. If investment burden continues in a period of weaker operating profit such as 2025, FCF may weaken and refinancing dependence may increase.

The current assessment of the capital structure is that guaranteed bonds and parent consolidated cash support short-term liquidity, but DL Chemical group's stand-alone unsecured credit carries a heavy financial burden. The KDB-guaranteed Kraton bond is a very significant support at the bond level. For DL Chemical group credit outside the guarantee, however, Kraton earnings recovery, chemical business FCF, parent support, and management of short-term debt and capex will determine the credit view.

7. Rating Agency View

In reading ratings, the KDB-guaranteed Kraton bond and Kraton stand-alone must always be separated. Moody's headline dated 26 June 2024 states that it assigned Aa2 to the notes to be issued by Kraton and guaranteed by KDB. Aa2 is a bond-level assessment based on the KDB guarantee and does not indicate the credit quality of Kraton's business on a stand-alone basis. KDB is a Korean policy financial institution, and the credit assessment of guaranteed bonds depends heavily on KDB's ability to pay, its relationship with the government and the guarantee terms.

Related headlines on the same ResearchPool platform show, with respect to Kraton stand-alone, a credit opinion downgraded to B1 in June 2024 and a negative view in 2023 reflecting earnings deterioration, rising leverage and tight liquidity. Because the full reports have not been reviewed, detailed downgrade triggers or financial metrics are not stated here. However, the public headlines at least show that there is a large difference between Kraton's stand-alone credit and the credit quality of KDB-guaranteed bonds.

For DL Chemical domestic bonds and DL Holdings' domestic ratings, the latest original rating agency reports had not been obtained at the time of this initial report. DART/KRX extracts relating to domestic bond management agreements confirm financial ratio maintenance clauses for DL Chemical domestic bonds, but the way rating agencies assess the business profile, financial profile and parent support needs separate confirmation. In particular, whether any DL Chemical domestic bonds have guarantees from DL Holdings or DL E&C, and which bonds any such guarantee covers, must be confirmed before investing in individual bonds.

The points on which this report's analysis is likely to align with rating agency views are that Kraton's business diversification and market position are a degree of support, while earnings volatility, raw material prices, leverage and liquidity are constraints. A possible difference is that, for investors in the KDB-guaranteed bonds, guarantor credit is more central than issuer stand-alone credit, whereas an issuer report still needs to continue monitoring DL Chemical group's underlying credit. Investors should avoid using only the rating of the guaranteed bonds to place a high credit view on the issuer group as a whole.

8. Credit Positioning

In relative terms, DL Chemical group is not a stable investment-grade chemicals credit, but a structurally dependent credit with both a specialty chemical business base and post-acquisition leverage. The product positions of PB, Cariflex and Kraton are better factors than those of a simple commodity petrochemical company, but Kraton's 2025 loss, the decline in chemical profit, the net loss and acquisition-related goodwill and intangible assets are clear constraints.

Compared with major Korean chemical groups, DL Chemical group is not among the largest in scale or in direct capital market access as a listed company, but it differentiates itself through specialty products such as PB, Kraton and Cariflex. The Kraton acquisition broadened technology and distribution networks, but also introduced challenges in overseas operations, impairments, integration and earnings recovery. If Kraton normalises, the business base will strengthen; if normalisation is delayed, it will remain a large source of earnings volatility.

KDB-guaranteed Kraton bonds should be considered in a separate bucket from unsecured bonds linked to the same issuer group. The relative positioning of the guaranteed bonds is close to KDB credit and the guarantee terms, while unsecured DL Chemical group credit, DL Holdings parent credit and Kraton stand-alone credit depend on profitability in the chemicals business, liquidity, parent support and debt structure. Even investors in the guaranteed bonds should confirm price behaviour, liquidity, guarantee claim procedures and credit concentration to the guarantor if the issuer deteriorates.

Market spreads and live prices were not checked for this report, so no buy, sell, hold, cheapness or richness view is given. To judge relative value, the KDB-guaranteed Kraton bonds need to be compared with KDB's own dollar bonds, Korean policy bank-guaranteed bonds and Korean quasi-sovereigns of similar tenor; unsecured DL Chemical-related bonds need to be compared with Korean chemical companies, specialty chemical companies with acquisition leverage and parent-guaranteed domestic bonds. At this stage, the conclusion is that guaranteed bonds should be analysed primarily through the KDB guarantee terms, while unsecured credit should be analysed primarily through chemical profit and confirmation of Kraton normalisation.

9. Key Credit Strengths and Constraints

The first strength is the specialty product base of PB, Cariflex and Kraton. DL Chemical's PB is described on the official website as having a global leading position, and Cariflex has a high market position in synthetic rubber and latex for medical applications. Kraton has a broad application and customer base in SBC and Pine chemical. Compared with a pure commodity petrochemical company, these businesses are better positioned to protect margins through product specification, customer relationships, technical service and application diversification. The fact that applications such as medical, adhesives, packaging, paving, lubricants and consumer goods do not all collapse at exactly the same time during an economic downturn is credit-supportive.

The second strength is access to capital and banking relationships under DL Holdings, including funding access through the KDB guarantee. DL Chemical group is not a stand-alone mid-sized chemical company, but a core subsidiary of a Korean listed holding company. In 2025, disclosures indicating capital support from the parent or group were also observed, and Kraton raised USD1.0bn with a KDB guarantee. This is positive for normal-course refinancing capacity and supports short-term liquidity even in an earnings downturn such as 2025.

The third strength is business diversification by region and product. DL Chemical separate operates in Korea, Kraton in the US, Europe and Asia, and Cariflex through Singapore, Brazil and other locations. Applications are also broad, including PE, PB, EPO, SBC, Pine chemical, medical latex, film and adhesive materials. This provides a degree of diversification compared with a company dependent solely on Korea's domestic petrochemical cycle.

The first constraint is uncertainty around Kraton's earnings recovery. Kraton is large in revenue terms, so periods of low profit or losses directly depress the credit view for the group as a whole. Kraton's 4Q 2025 loss, spread compression, seasonal volume decline and Kraton impairment show that post-acquisition earnings capacity has not yet stabilised. Whether Kraton can recover through price revisions and production rationalisation is the central monitoring item for DL Chemical group.

The second constraint is the financial burden and weakness in net income. DL Holdings consolidated retained operating profit in 2025, but turned to a net loss. A structure in which interest, foreign exchange, equity-method results, impairments and acquisition-related costs weigh on net income is sensitive to leverage and refinancing costs. Looking at DL Chemical group alone, the asset base including Kraton and Cariflex is large, but liabilities are also substantial, and the equity buffer cannot be described as sufficiently thick. The fact that operating cash flow and FCF have not been directly confirmed also makes the unsecured credit assessment provisional.

The third constraint is raw materials, foreign exchange, interest rates and capex. PE, PB, SBC, Pine chemical and medical latex are all affected by raw material prices and utilisation rates. Movements in the won, dollar, euro and raw-material currencies affect profit and loss, inventory, foreign-currency debt and acquisition-related valuations. When interest rates are high, the debt cost after the Kraton acquisition weighs on profit. Capex, production rationalisation and environmental investment at Cariflex and Kraton can also weaken FCF in the short term.

The fourth constraint is structural complexity. DL Holdings, DL Chemical, DLC US Holdings, Kraton, Cariflex, related JVs, KDB-guaranteed bonds and domestic public bonds coexist, so investors need to confirm which funding source reaches which bond. Guaranteed and unsecured bonds, parent and subsidiary bonds, and domestic and offshore bonds have different levels of protection. Misreading the structure can easily lead to overestimating credit quality.

10. Downside Scenarios and Monitoring Triggers

The most realistic downside scenario is a path in which Kraton's earnings recovery is delayed while DL Chemical separate's PE/PB margins also remain weak. Even if revenue remains at a certain scale, operating margins could stay low, operating cash flow could be eroded by inventories, receivables and raw material prices, and FCF could be pressured by capex and interest. For KDB-guaranteed bonds, final protection for interest and principal may shift to KDB, but when the issuer deteriorates, bond price, liquidity, guarantee claim procedures and credit concentration to the guarantor become issues.

The second downside scenario is simultaneous stress in raw material prices, foreign exchange and interest rates. If naphtha, butadiene, styrene, isoprene, crude tall oil and logistics costs rise, and KRW weakness, USD strength and higher interest rates overlap, costs, inventories, finance expenses and foreign-currency debt valuation can deteriorate at the same time. Even if part of the increase can be passed through through price revisions, full pass-through may take time because of demand and competition.

The third is additional impairment of goodwill and intangible assets related to the Kraton acquisition, together with restructuring costs. Given that Kraton impairment weighed on profit and loss in 2025, if earnings recovery is delayed, additional impairments or production rationalisation costs could again worsen net income and refinancing market perception. Cariflex expansion, Kraton production rationalisation and DL Chemical investment in higher-value-added products may be positive over the long term, but can weaken FCF in the short term.

The monitoring indicators are clear. First, Kraton's quarterly revenue, operating profit, utilisation, price revisions and separate profitability for Pine chemical and Polymer. Second, DL Chemical separate's PB/PE margins, sales volume and raw-material lag. Third, whether Cariflex maintains its high margin. Fourth, DL Chemical group's operating cash flow, FCF, gross debt, short-term debt, interest expense, foreign-currency debt and legal-entity cash. Fifth, the guarantee terms of the KDB-guaranteed bonds, KDB's rating and regulatory or contractual events relating to the guarantee.

On ratings and markets, investors should monitor Kraton stand-alone rating actions, KDB's rating and outlook, market views on Korean policy financial institutions, domestic ratings for DL Chemical domestic bonds, and DL Holdings' ratings and funding conditions. Market prices and spreads were not checked in this report, but for the guaranteed Kraton bonds, the spread to KDB bonds is important; for unsecured related bonds, spreads versus Korean chemical companies and chemical companies with acquisition leverage are important.

11. Credit View and Monitoring Focus

DL Chemical group's current unsecured stand-alone credit quality should be treated as a carefully monitored post-acquisition leveraged credit, not as a stable investment-grade credit, because although it has support from specialty products, Kraton's low profitability and unconfirmed cash flow and debt data remain constraints. The specialty chemical base in PB, Cariflex and Kraton supports the business floor, but given the decline in DL Chemical consolidated operating profit in 2025 and Kraton's loss, the credit is not yet at a stage where it should be treated as a strong investment-grade stable chemical credit. The credit direction is flat to awaiting gradual recovery before stabilisation is confirmed, despite signs of recovery in 1Q 2026, and should be viewed cautiously until Kraton earnings normalisation and FCF improvement are confirmed. The probability of rapid credit deterioration is reduced for KDB-guaranteed bonds as long as the guarantee functions effectively, but for DL Chemical group unsecured credit, headroom can shrink easily if Kraton deteriorates again and interest rates, foreign exchange and additional impairments overlap.

This credit view is supported by the high market position in PB, Cariflex's high profitability, Kraton's broad application diversification, capital and banking relationships under DL Holdings, and refinancing support from the KDB-guaranteed bond. In particular, if the KDB-guaranteed Kraton bond is confirmed to have ordinary strong guarantee terms, it would be a very significant credit enhancement at the bond level, and the credit risk of that bond would move closer to KDB credit rather than DL Chemical group stand-alone.

The constraints, however, are clear. If Kraton's earnings remain weak, DL Chemical group's profit level is thin. The sharp decline in chemical profit in 2025 and DL Holdings consolidated net loss show combined stress from petrochemicals, specialty chemicals, acquisition burden and non-operating expenses. DL Holdings' consolidated cash is supportive, but as long as the location of legal-entity cash and debt remains unconfirmed, it cannot be assumed to flow directly to Kraton creditors or DL Chemical domestic bondholders.

From an investor's perspective, monitoring should focus on Kraton's operating profit recovery, DL Chemical separate's PB/PE margins, maintenance of Cariflex's high margin, operating cash flow and FCF, short-term debt and foreign-currency debt, the terms of the KDB-guaranteed bond, and capital support from parent DL Holdings. If the 1Q 2026 recovery is not merely quarterly and leads to Kraton price revisions, utilisation, cost reductions and margin improvement in DL Chemical PB/PE, the credit view could stabilise. Conversely, if Kraton posts another loss, additional impairments occur, operating cash flow is weak, parent support is limited or there is uncertainty in the guarantee terms, caution should increase for unsecured credit.

The practical conclusion of this report is that, subject to confirmation of the guarantee agreement and OC, KDB-guaranteed Kraton bonds should be assessed primarily on post-guarantee credit, while DL Chemical group's unsecured credit should be treated conservatively until Kraton normalises. The most important point in initial coverage is not to confuse KDB-guaranteed bonds and Kraton stand-alone merely because of the KRA name.

12. Short Summary & Conclusion

DL Chemical group is a chemicals and specialty materials group under Korea's DL Holdings, with PE/PB/EPO, Kraton's SBC and Pine chemical businesses, and Cariflex's synthetic rubber and latex for medical applications. The product positions of PB, Cariflex and Kraton are supportive, but Kraton's low profitability and post-acquisition burden are the main issues. For KRA-related exposure, investors need to distinguish between the post-guarantee credit of KDB-guaranteed Kraton bonds and the unsecured underlying credit of DL Chemical group.

13. Sources

Primary company and regulatory sources

• DL Chemical official website, Group Highlights, accessed 2026-05-18. DL Group highlights, petrochemical/energy product positioning, PB, Cariflex, Kraton and affiliate overview.
• DL Chemical official website, Information / Introduction / Business / History, accessed 2026-05-18. DL Chemical business profile, PB market position, Cariflex, Kraton, YNCC, PolyMirae and global locations.
• DL Holdings official IR page, accessed 2026-05-18. IR material availability and 2026 1Q materials listing.
• DL Holdings official Financial Information page, accessed 2026-05-18. 2021-2025 consolidated income statement.
• KRX / DART mirrored DL Holdings 2025 annual report and 2025 quarterly report excerpts, accessed 2026-05-18. Subsidiary structure, DL Chemical ownership, DL Holdings consolidated financial statement excerpts, DL Chemical/Kraton/Cariflex business and R&D notes, covenant snippets.
• Kraton Corporation, "Kraton Corporation Completes Merger With DL Chemical", 2022-03-15. Acquisition completion, transaction value and business profile.
• Kraton Corporation, "Kraton and DL Chemicals Successfully Raise USD 1 Billion in Global Bonds with KDB Credit Guarantee", 2024-07-11. Kraton global bond issuance and KDB guarantee.

Rating agency and market-source references

• Moody's Ratings headline via ResearchPool, "Moody's Ratings assigns Aa2 rating to Kraton's proposed notes guaranteed by KDB", 2024-06-26. Public headline and issuer profile only; full report not accessed.
• MarketScreener / Publicnow mirror, "DL: 2025 4Q Earnings Results", published 2026-02-09. DL Holdings and segment performance, DL Chemical / Kraton / Cariflex data.
• MarketScreener / Publicnow mirror, "DL: 2025 2Q Earnings Results" and "DL: 2025 3Q Earnings Results", accessed 2026-05-18. Segment trends and chemical business comments.
• ChosunBiz English and Starnews English, DL 2026 1Q preliminary result reports, 2026-05-08 to 2026-05-10. 2026 1Q consolidated preliminary sales, operating profit and petrochemical recovery commentary.

Internal working sources

• internal working memo: initial coverage task for DL Chemical group.
• internal data extract: issuer_summary/issuers/dl_chemical_group/data/dl_chemical_group_financial_extract_20260518.json

Unverified / Pending items